1 – 84 of 84
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Centrally and peripherally altered glucose transporters : is it time to revisit energy deficiency as a potential treatment strategy in Huntington's disease?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Inflammation Biomarkers in Huntington’s Disease
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Altered Adipocyte Cell Size Distribution Prior to Weight Loss in the R6/2 Model of Huntington's Disease
(
- Contribution to journal › Article
-
Mark
Mutant huntingtin expression in the hypothalamus promotes ventral striatal neuropathology
2023)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Preserved blood-brain barrier and neurovascular coupling in female 5xFAD model of Alzheimer's disease
(
- Contribution to journal › Article
- 2022
-
Mark
Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice
(
- Contribution to journal › Article
-
Mark
Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
2022)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Skeletal muscle regeneration is altered in the R6/2 mouse model of Huntington’s disease
2022) p.1-23(
- Working paper/Preprint › Preprint in preprint archive
- 2021
-
Mark
Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
(
- Contribution to journal › Article
- 2020
-
Mark
Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s disease
(
- Contribution to journal › Article
-
Mark
A hypothesis for insulin resistance in primary human adipocytes involving MRTF-A and suppression of PPARγ
(
- Contribution to journal › Article
- 2019
-
Mark
Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease
(
- Contribution to journal › Article
- 2018
-
Mark
A critical evaluation of wet biomarkers for huntington's disease : Current status and ways forward
(
- Contribution to journal › Scientific review
-
Mark
Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington's Disease
(
- Contribution to journal › Article
-
Mark
Brain pericyte activation occurs early in Huntington's disease
(
- Contribution to journal › Article
-
Mark
Perturbations in the p53/miR-34a/SIRT1 pathway in the R6/2 Huntington's disease model
(
- Contribution to journal › Article
-
Mark
A51 Genetically altering metabolism by leptin-deficiency affects peripheral disease features in the R6/2 mouse model of huntington´s disease
2018) European Huntington Disease Network conference 2018 In Journal of Neurology, Neurosurgery and Psychiatry 89(Suppl 1). p.18-18(
- Contribution to journal › Published meeting abstract
-
Mark
Effects of dual administration of liraglutide and ghrelin on brain mitochondrial metabolism in the r6/2 mouse
2018) European Huntington Disease Network conference 2018 In Journal of Neurology, Neurosurgery and Psychiatry 89(Suppl 1). p.92-92(
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease
(
- Contribution to journal › Article
- 2016
-
Mark
A Metabolic Study of Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease : increased NPY levels and differential degradation of the NPY1-30 fragment
(
- Contribution to journal › Article
-
Mark
White adipose tissue browning in the R6/2 mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Immunomodulation - a disease-modifying avenue for treatment of Huntington's disease?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin
(
- Contribution to journal › Article
-
Mark
L23 Effects of peripheral (co-)administration of liraglutide and ghrelin in the R6/2 mouse brain function
2016) European Huntington Disease Network conference 2016 In Journal of Neurology, Neurosurgery and Psychiatry 87(Suppl 1). p.98-98(
- Contribution to journal › Published meeting abstract
-
Mark
L24 The effect of ghrelin administration in the R6/2 mouse model of Huntington’s disease
2016) European Huntington Disease Network conference 2016 In Journal of Neurology, Neurosurgery and Psychiatry 87(Suppl 1).(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Characterization of Gastric Mucosa Biopsies Reveals Alterations in Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models.
(
- Contribution to journal › Article
-
Mark
Analysis of White Adipose Tissue Gene Expression Reveals CREB1 Pathway Altered in Huntington's Disease.
(
- Contribution to journal › Article
- 2014
-
Mark
Inflammatory Markers in Huntington’s Disease Plasma – A Robust NanoLC-MRM-MS Assay Development
(
- Contribution to journal › Article
-
Mark
HTT-lowering reverses Huntington's disease immune dysfunction caused by NF kappa B pathway dysregulation
(
- Contribution to journal › Article
-
Mark
Flt3 ligand does not differentiate between Parkinsonian disorders.
(
- Contribution to journal › Article
-
Mark
A porous silicon immunoassay platform for fluorometric determination of alpha-synuclein in human cerebrospinal fluid
(
- Contribution to journal › Article
-
Mark
Plasma Melatonin Is Reduced in Huntington's Disease
(
- Contribution to journal › Article
-
Mark
Skeletal muscle atrophy in r6/2 mice - altered circulating skeletal muscle markers and gene expression profile changes.
(
- Contribution to journal › Article
- 2013
-
Mark
JAK/STAT Signalling in Huntington's Disease Immune Cells.
(
- Contribution to journal › Article
-
Mark
A Critical Evaluation of Inflammatory Markers in Huntington’s Disease Plasma
(
- Contribution to journal › Article
- 2012
-
Mark
No diagnostic value of plasma clusterin in Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Bone Marrow Transplantation Confers Modest Benefits in Mouse Models of Huntington's Disease.
2012) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 32(1). p.133-142(
- Contribution to journal › Article
-
Mark
Automated Behavioral Phenotyping Reveals Presymptomatic Alterations in a SCA3 Genetrap Mouse Model
(
- Contribution to journal › Article
-
Mark
Increased levels of hemoglobin and alpha1-microglobulin in Huntington's disease.
(
- Contribution to journal › Article
- 2011
-
Mark
Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease
(
- Contribution to journal › Article
-
Mark
IGF-1 protects against diabetic features in an in vivo model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice.
(
- Contribution to journal › Article
-
Mark
Abnormal peripheral chemokine profile in Huntington's disease.
(
- Contribution to journal › Article
- 2010
-
Mark
Serum levels of a subset of cytokines show high interindividual variability and are not altered in rats transgenic for Huntington´s disease.
(
- Contribution to journal › Article
-
Mark
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
(
- Contribution to journal › Article
- 2009
-
Mark
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
(
- Contribution to journal › Article
-
Mark
Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model
(
- Contribution to journal › Article
-
Mark
Beyond the brain: widespread pathology in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity.
(
- Contribution to journal › Article
-
Mark
Harnessing immune alterations in neurodegenerative diseases.
(
- Contribution to journal › Article
-
Mark
Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt.
(
- Contribution to journal › Article
- 2008
-
Mark
Cocaine and amphetamine regulated transcript (CART) in suicide attempters.
(
- Contribution to journal › Article
-
Mark
Increased metabolism in the R6/2 mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Increased thirst and drinking in Huntington's disease and the R6/2 mouse
(
- Contribution to journal › Article
-
Mark
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
2008) EHDN Annual Meeting In Journal of Neurology, Neurosurgery and Psychiatry 79(Supplement 1). p.4-4(
- Contribution to journal › Published meeting abstract
-
Mark
Islet beta-cell area and hormone expression are unaltered in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease.
(
- Contribution to journal › Article
- 2007
-
Mark
Cocaine- and amphetamine-regulated transcript is increased in Huntington disease.
(
- Contribution to journal › Article
-
Mark
Testicular degeneration in Huntington disease
(
- Contribution to journal › Article
-
Mark
Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder.
(
- Contribution to journal › Article
-
Mark
Orexin and psychiatric symptoms in suicide attempters.
(
- Contribution to journal › Article
-
Mark
Ghrelin and motilin are cosecreted from a prominent endocrine cell population in the small intestine
(
- Contribution to journal › Article
- 2006
-
Mark
Hypothalamic-endocrine aspects in Huntington's disease.
(
- Contribution to journal › Scientific review
-
Mark
Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.
(
- Contribution to journal › Letter
-
Mark
Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
CART Regulates Islet Hormone Secretion and Is Expressed in the {beta}-Cells of Type 2 Diabetic Rats.
(
- Contribution to journal › Article
- 2005
-
Mark
Somatostatin, misoprostol and galanin inhibit gastrin- and PACAP-stimulated secretion of histamine and pancreastatin from ECL cells by blocking specific Ca(2+) channels.
(
- Contribution to journal › Article
-
Mark
Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.
(
- Contribution to journal › Article
-
Mark
Orexin loss in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice
(
- Contribution to journal › Article
- 2003
-
Mark
Submucosal microinfusion of endothelin and adrenaline mobilizes ECL-cell histamine in rat stomach, and causes mucosal damage: a microdialysis study.
(
- Contribution to journal › Article
- 2002
-
Mark
Role of gastrin in the development of gastric mucosa, ECL cells and A-like cells in newborn and young rats
(
- Contribution to journal › Article
-
Mark
The Gastrin-ECL Cell Axis. Functional Aspects
2002)(
- Thesis › Doctoral thesis (compilation)
- 2001
-
Mark
A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control
(
- Contribution to journal › Article
-
Mark
Gastrin and the neuropeptide PACAP evoke secretion from rat stomach histamine-containing (ECL) cells by stimulating influx of Ca2+ through different Ca2+ channels
(
- Contribution to journal › Article
-
Mark
Cell-specific processing of chromogranin A in endocrine cells of the rat stomach
(
- Contribution to journal › Article
-
Mark
Effects of CCK2 receptor blockade on growth parameters in gastrointestinal tract and pancreas in rats
(
- Contribution to journal › Article